Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.

Next Previous
Trial Profile

Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Fibromyalgia; Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Eli Lilly and Company

Most Recent Events

  • 08 May 2010 Results were presented at the 29th Annual Scientific Meeting of the American Pain Society.
  • 19 Aug 2009 Actual patient number (513) added as reported by ClinicalTrials.gov.
  • 19 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top